This systematic review aims to critically appraise the existing literature which utilizes PSMA PET in localized low- to intermediate-risk PCa to determine if it could help improve risk stratification and selection of patients for active surveillance. The gene discussed is FOLH1; the disease is posterior cortical atrophy.